<?xml version="1.0" encoding="UTF-8"?>
<p>To determine the inhibitory effect of soluble heparin on EV-A71 variants, a virus inactivation assay was performed as previously described [
 <xref rid="ppat.1007863.ref009" ref-type="bibr">9</xref>]. In brief, viruses were incubated with 2.5 mg/ml of soluble heparin (Sigma, USA) for an hour at 37°C. The treated viruses were inoculated onto pre-seeded RD cells and incubated at 37°C. Two days later, the cell viability of each infected virus variants was measured using CellTiter 96 Aqueous One solution Cell Proliferation Assay (Promega, USA). The relative cell viability was calculated with the following formula: 
 <disp-formula id="ppat.1007863.e001">
  <alternatives>
   <graphic xlink:href="ppat.1007863.e001.jpg" id="ppat.1007863.e001g" mimetype="image" position="anchor" orientation="portrait" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   <math id="M1">
    <mtext>Relative</mtext>
    <mspace width="2pt"/>
    <mtext>cell</mtext>
    <mspace width="2pt"/>
    <mtext>viability</mtext>
    <mo>=</mo>
    <mfrac>
     <mrow>
      <mtext>Absorbance</mtext>
      <mspace width="2pt"/>
      <mtext>of</mtext>
      <mspace width="2pt"/>
      <mtext>well</mtext>
      <mspace width="2pt"/>
      <mtext>inoculated</mtext>
      <mspace width="2pt"/>
      <mtext>with</mtext>
      <mspace width="2pt"/>
      <mtext>treated</mtext>
      <mspace width="2pt"/>
      <mtext>virus</mtext>
      <mspace width="2pt"/>
      <mtext>sample</mtext>
     </mrow>
     <mrow>
      <mtext>Absorbance</mtext>
      <mspace width="2pt"/>
      <mtext>of</mtext>
      <mspace width="2pt"/>
      <mtext>well</mtext>
      <mspace width="2pt"/>
      <mtext>inoculated</mtext>
      <mspace width="2pt"/>
      <mtext>with</mtext>
      <mspace width="2pt"/>
      <mtext>untreated</mtext>
      <mspace width="2pt"/>
      <mtext>virus</mtext>
      <mspace width="2pt"/>
      <mtext>sample</mtext>
     </mrow>
    </mfrac>
   </math>
  </alternatives>
 </disp-formula>
</p>
